SAT-251 Semaglutide can reduce alcohol use in patients with metabolic dysfunction-associated steatotic liver disease.
Saved in:
| Title: | SAT-251 Semaglutide can reduce alcohol use in patients with metabolic dysfunction-associated steatotic liver disease. |
|---|---|
| Authors: | Fomin, Vladislav (AUTHOR), Buckholz, Adam (AUTHOR), Liu, Yihan (AUTHOR), Mallick, Himel (AUTHOR), Kumar, Sonal (AUTHOR) |
| Source: | Journal of Hepatology. 2024 Supplement 1, Vol. 80, pS138-S138. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01688278 |
|---|---|
| DOI: | 10.1016/S0168-8278(24)00700-1 |
